Skip to main content
Megan Rahmlow, MD, Neurology, Brentwood, TN

Megan R Rahmlow MD

Neuroimmunology/Multiple Sclerosis, Neurophysiology


Medical Director, Neurology at Icon plc

Join to View Full Profile
  • 320 Seven Springs Waysuite 500Brentwood, TN 37027

Dr. Rahmlow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Medical Director, Neurology, Medical Affairs at Icon. Experience in neuroscience clinical research as an investigator and with a CRO.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Neuroimmunology & Multiple Sclerosis, 2011 - 2012
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Clinical Neurophysiology, 2010 - 2011
  • Mayo Clinic College of Medicine and Science (Jacksonville)
    Mayo Clinic College of Medicine and Science (Jacksonville)Residency, Neurology, 2007 - 2010
  • Mayo Clinic College of Medicine and Science
    Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2006 - 2007
  • University of Missouri Kansas City School of Medicine
    University of Missouri Kansas City School of MedicineClass of 2006

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2014 - 2026
  • FL State Medical License
    FL State Medical License 2007 - 2015
  • MN State Medical License
    MN State Medical License 2011 - 2013
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Press Mentions

  • Drug’s Effectiveness for Neurosarcoidosis Studied
    Drug’s Effectiveness for Neurosarcoidosis StudiedNovember 16th, 2017

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: